Wednesday, June 04, 2025 | 06:51 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lupin Pharma launches Lurasidone Hydrochloride Tablets in US

The generic equivalent of Latuda tablets has been launched in the US markets

lupin
premium

BS Web Team New Delhi

Lupin Limited, a global pharmaceutical company, has announced the launch of Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, to market a generic equivalent of Latuda Tablets of Sunovion Pharmaceuticals, Inc. Lupin filed this update with the Bombay Stock Exchange. It issued a press release informing the public of the same.

The generic equivalent of Latuda tablets has been launched in the US markets. Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales of $4.2 billion in the US, according